Literature DB >> 35199291

Analysis of surgical approach and tumor distance to margin after liver resection for colorectal liver metastasis.

Emanuel Shapera1, Sharona Ross1, Kaitlyn Crespo1, Cameron Syblis1, Valerie Przetocki1, Alexander Rosemurgy1, Iswanto Sucandy2.   

Abstract

This study was undertaken to compare tumor distance to margin after robotic vs. open hepatectomy for colorectal liver metastases (CLM) and to determine the relationship between perioperative variables, surgical approach and tumor distance to margin with overall survival. With IRB approval, we followed 56 patients who underwent a robotic or open hepatectomy for treatment of CLM. The relationships between the tumor distance to margin, operative approach, perioperative variables and survival was determined. The robotic approach yielded greater margins than the open approach (p = 0.04). The robotic vs. open approach had an operative duration of 375 vs. 269 min (p = 0.05), ICU length of stay (LOS) of 0 vs. 1 day (p = 0.01), and hospital LOS of 4 vs. 7 days (p = 0.04). Patients with a tumor distance to margin of ≤ 1 mm and 1.1-9.9 mm had an estimated median survival of 49 months and 24 months, respectively. Estimated median survival for patients with tumor distance to margin of ≥ 10 mm has not been reached but is > 84 months. The use of the robotic approach is associated with greater tumor distance to margin and shorter hospital LOS, but with longer operations. The robotic approach does not compromise oncological margins during resection for CLM.
© 2022. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

Entities:  

Keywords:  Colorectal metastases; Margin; Robotic hepatectomy

Year:  2022        PMID: 35199291     DOI: 10.1007/s11701-022-01387-9

Source DB:  PubMed          Journal:  J Robot Surg        ISSN: 1863-2483


  8 in total

1.  [Risk factor analysis of early recurrence after resection of colorectal liver metastasis].

Authors:  Wei Liu; Xiaoluan Yan; Kun Wang; Quan Bao; Yi Sun; Hongwei Wang; Kemin Jin; Baocai Xing
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2015-11

2.  Robotic Resection of a Type IIIB Klatskin Tumor.

Authors:  Iswanto Sucandy; Sharona Ross; Alexander Rosemurgy
Journal:  J Gastrointest Surg       Date:  2021-03-16       Impact factor: 3.452

3.  Robotic Major Hepatectomy: An Institutional Experience and Clinical Outcomes.

Authors:  Iswanto Sucandy; Kenneth Luberice; Trenton Lippert; Miguel Castro; Emily Krill; Sharona Ross; Alexander Rosemurgy
Journal:  Ann Surg Oncol       Date:  2020-07-13       Impact factor: 5.344

4.  Robotic hepatectomy for benign and malignant liver tumors.

Authors:  Iswanto Sucandy; Sydni Schlosser; Timothy Bourdeau; Janelle Spence; Abdelrahman Attili; Sharona Ross; Alexander Rosemurgy
Journal:  J Robot Surg       Date:  2019-02-23

5.  The effect of the robotic platform in hepatectomy after prior liver and non-liver abdominal operations: a comparative study of clinical outcomes.

Authors:  Iswanto Sucandy; Emanuel Shapera; Kaitlyn Crespo; Cameron Syblis; Valerie Przetocki; Sharona Ross; Alexander Rosemurgy
Journal:  J Robot Surg       Date:  2021-11-26

6.  Institutional First 100 Case Experience and Outcomes of Robotic Hepatectomy for Liver Tumors.

Authors:  Iswanto Sucandy; Andres Giovannetti; Sharona Ross; Alexander Rosemurgy
Journal:  Am Surg       Date:  2020-03-01       Impact factor: 0.688

7.  Robotic resection of extrahepatic cholangiocarcinoma: Institutional outcomes of bile duct cancer surgery using a minimally invasive technique.

Authors:  Iswanto Sucandy; Emanuel Shapera; Kevin Jacob; Kenneth Luberice; Kaitlyn Crespo; Cameron Syblis; Sharona B Ross; Alexander S Rosemurgy
Journal:  J Surg Oncol       Date:  2021-09-15       Impact factor: 3.454

  8 in total
  1 in total

1.  Survival Study: International Multicentric Minimally Invasive Liver Resection for Colorectal Liver Metastases (SIMMILR-2).

Authors:  Andrew A Gumbs; Roland Croner; Eric Lorenz; Andrea Benedetti Cacciaguerra; Tzu-Jung Tsai; Lee Starker; Joe Flanagan; Ng Jing Yu; Elie Chouillard; Mohammad Abu Hilal
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.